These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21246)

  • 21. The effects of selective dopamine receptor agonists and antagonists on body temperature in rats.
    Faunt JE; Crocker AD
    Eur J Pharmacol; 1987 Jan; 133(3):243-7. PubMed ID: 2951265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine agonists and audiogenic seizures: the relationship between protection against seizures and changes in monoamine metabolism.
    Anlezark GM; Horton RW; Meldrum BS
    Biochem Pharmacol; 1978; 27(24):2821-8. PubMed ID: 581645
    [No Abstract]   [Full Text] [Related]  

  • 23. Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnover.
    Snider SR; Hutt C; Stein B; Prasad AL; Fahn S
    J Pharm Pharmacol; 1976 Jul; 28(7):563-6. PubMed ID: 8610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New central dopamine agonists.
    Borsy J
    Pol J Pharmacol Pharm; 1985; 37(3):227-36. PubMed ID: 2999737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lergotrile and lisuride: in vivo dopaminergic agonists which do not stimulate the presynaptic dopamine autoreceptor.
    Kebabian JW; Kebabian PR
    Life Sci; 1978 Nov; 23(22):2199-203. PubMed ID: 31541
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective affinities of bromocriptine and lergotrile for rat limbic dopamine binding sites [proceedings].
    Blackburn KJ; Bremner RM; Greengrass PM; Morville M; Davey MJ
    Br J Pharmacol; 1978 Nov; 64(3):413P. PubMed ID: 31219
    [No Abstract]   [Full Text] [Related]  

  • 27. Bromocriptine enhances guanylate cyclase activity.
    Vesely DL
    Endocrinology; 1981 Oct; 109(4):1284-6. PubMed ID: 6116597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of D1 dopamine receptor mechanism in ischemia-induced impairment of CA1 presynaptic fiber spikes in rat hippocampal slices.
    Yamamoto Y; Tanaka T; Shibata S; Watanabe S
    Brain Res; 1994 Nov; 665(1):151-4. PubMed ID: 7882009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of the central dopaminergic stimulants apomorphine and lergotrile.
    Wade RL; Krewsun I; Quock RM
    Proc West Pharmacol Soc; 1979; 22():141-2. PubMed ID: 42079
    [No Abstract]   [Full Text] [Related]  

  • 30. Proceedings: CF 25-397 (9, 10-didehydro-6-methyl-8beta-(2-pyridylthiomethyl) ergoline), a new central dopamine receptor agonist.
    Jaton AL; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Mar; 56(3):371P. PubMed ID: 944059
    [No Abstract]   [Full Text] [Related]  

  • 31. Differences in the dopaminergic effects of the ergot derivatives bromocriptine, lisuride and d-LSD as compared with apomorphine.
    Horowski R
    Eur J Pharmacol; 1978 Sep; 51(2):157-66. PubMed ID: 699981
    [No Abstract]   [Full Text] [Related]  

  • 32. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
    Hutt CS; Snider SR; Fahn S
    Neurology; 1977 Jun; 27(6):503-10. PubMed ID: 577299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre- and postsynaptic action of bromocriptine: its pharmacological effects on shcizophrenia and neurological diseases.
    Trabucchi M; Andreoli VM; Frattola L; Spano PF
    Adv Biochem Psychopharmacol; 1977; 16():661-5. PubMed ID: 196497
    [No Abstract]   [Full Text] [Related]  

  • 35. In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphine.
    Benedetti MS; Dostert P; Barone D; Efthymiopoulos C; Peretti G; Roncucci R
    Eur J Pharmacol; 1990 Oct; 187(3):399-408. PubMed ID: 1981553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the effects of CB-154 and lergotrile mesylate on prolactin and growth hormone secretion in mice.
    Sinha YN; Salocks CB; VanderLaan WP
    Horm Metab Res; 1976 Sep; 8(5):332-6. PubMed ID: 989755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of (8beta)-8-[methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in rats.
    Fuller RW; Clemens JA; Kornfeld EC; Snoddy HD; Smalstig EB; Bach NJ
    Life Sci; 1979 Jan; 24(4):375-82. PubMed ID: 34767
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dopaminergic blockage using pimozide and dopaminergic stimulation using bromocryptin. Effect on secretion of somatotropin].
    Hainer V; Krejcík L; Urbánek J; Tvaroh F
    Cas Lek Cesk; 1977 Jan; 116(2):11-6. PubMed ID: 576415
    [No Abstract]   [Full Text] [Related]  

  • 39. Variability and selectivity of anterior pituitary response to dopamine agonists throughout the normal menstrual cycle.
    Kletzky OA; Shangold GA
    Am J Obstet Gynecol; 1986 Feb; 154(2):362-7. PubMed ID: 3080890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential sensitivity of spontaneously hypertensive rats to the hypothermic effect of dopaminergic drugs.
    Martin JR; Quock RM
    Life Sci; 1980 Jul; 27(3):253-8. PubMed ID: 7401934
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.